Article List

WPRIM Management System> DCMS> Journal of International Oncology> 2017> 44> 6

Volume: 44 Issue: 6

1. Adverse reactions of the new generation of tumor immunotherapy and its management strategy	Page:460—463
2. Research advances of cancer therapy targeting HIF-1α-VEGF-VEGFR-2 signaling pathway for malignant tumors	Page:456—459
3. Anti-cancer effects of Alternol and Alteronol on human cancers	Page:452—455
4. Research progress of miR-151-5p in tumor	Page:445—447
5. Research progress of Dickkopf-1 related tumor metastasis	Page:442—444
6. Exosomal microRNAs and their roles in tumors	Page:438—441
7. Expression and clinical value of NRP-1 in hepatocellular carcinoma	Page:428—432
8. Clinical value and toxicities of docetaxel plus capecitabine in the first line treatment of metastatic breast cancer	Page:423—427
9. Expression and clinical significance of C1orf63 in breast cancer	Page:420—422
10. Expressions of HIF-1α and CA9 in breast carcinoma and their relationships with basal-like subtype	Page:415—419
11. Expression of C2orf40 protein and its clinical significance in human nasopharyngeal carcinoma	Page:406—410
12. Study of signal transduction mechanisms of X-ray induced multidrug resistance in nasopharyngeal squamous cell carcinoma CNE1 cells	Page:401—405
13. Research progress of glucocorticoid receptor in urological malignant tumors	Page:476—479
14. Progress of ALK gene inhibitors in the treatment of brain metastases from non-small cell lung cancer	Page:472—475
15. Application of anti-angiogenesis therapy in the radiotherapy of esophageal cancer	Page:468—471
16. Research progress of electric field in the treatment of glioma	Page:464—467
17. Mechanism of anti-tumor effect of dihydroartemisinin	Page:448—451
18. Relationship between APC gene 3'-untranslated region rs1804197 polymorphism and colorectal cancer susceptibility	Page:433—437
19. Expressions and clinical significances of ATF3 and Runx2 in breast carcinoma	Page:411—414